Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs AT&T Inc. (T) Price & Performance

BioNTech SE - ADRTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs AT&T Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while AT&T Inc. trades at $24.4 (market cap $167.88B). The key difference: AT&T Inc. is far larger — about 7.2× BioNTech SE - ADR's market cap, and AT&T Inc. pays a 4.53% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

BNTXT
Market Cap
$23.31B$167.88B
Sector
HealthMedia
52-Week High
$119.34$29.62
52-Week Low
$83.89$20.49
Enterprise Value
$6.60B$313.20B
Dividend Yield
4.53%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About AT&T Inc.

AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.

Read more on T